Biopharmaceutical Industry in the United States: Market Research Reports, Statistics and Analysis

Intercell Ag - Company Report For Year 2013

... And production of rare, fully human monoclonal antibodies are offered by vivalis. Through these programs, vivalis receives payments associated with the funding of discovery research, an upfront payment, clinical ...

Biosimilar Market Analysis In The United States And Japan

... Be treated as a unique entity diclofenac = monoclonal antibodies shown within the circles: the reference product and each biosimilar has different post-translational modifications (in this case ...

Company Report: Protein In The United States For Year 2013

... Therapeutics for folding diseases or folding solutions are difficult to develop because proteins are moving targets }disease or misfolding n o ye s -high throughput readout signal -- yes/no decrease ...

New Enterprise Associates - Company Report For Year 2013

U.s. Antibody Industry Brief

... Selection antibody generation assay development cell line development bio-analytical assay development manufacturing research process optimization product positioning research poc studies additional ...

Company Report: Biopharmaceutical In The United States For Year 2 ...

Company Report: Biopharmaceutical In Israel And The United States ...

Vaccine Market Statistics In The United States And Canada

Pfizer Inc. - Company Report For Year 2012

... To as Follow-on biologics ). Such biosimilars would reference biotechnology products approved under the u.S. Public health service act. Additionally, the fda has approved a biosimilar recombinant human growth ...